These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21681744)

  • 1. Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma.
    Marion A; Dieudonné FX; Patiño-Garcia A; Lecanda F; Marie PJ; Modrowski D
    Int J Cancer; 2012 Jun; 130(11):2514-25. PubMed ID: 21681744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
    Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
    Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
    Dieudonné FX; Marion A; Marie PJ; Modrowski D
    J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.
    Dieudonné FX; Marion A; Haÿ E; Marie PJ; Modrowski D
    Cancer Res; 2010 Jul; 70(13):5399-408. PubMed ID: 20530678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
    Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
    Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
    Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
    Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
    Luk F; Yu Y; Walsh WR; Yang JL
    Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 gene polymorphisms and risk of chemoresistant pediatric osteosarcoma.
    Zhou Y; Liu B; Wang M; Ni J
    Pediatr Blood Cancer; 2014 Apr; 61(4):612-7. PubMed ID: 24123836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling.
    Xia YZ; Ni K; Guo C; Zhang C; Geng YD; Wang ZD; Yang L; Kong LY
    Phytomedicine; 2015 Mar; 22(3):344-51. PubMed ID: 25837271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma.
    Dai H; Huang Y; Li Y; Meng G; Wang Y; Guo QN
    Carcinogenesis; 2012 Jan; 33(1):30-40. PubMed ID: 22021909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling.
    Daqian W; Chuandong W; Xinhua Q; Songtao A; Kerong D
    Chem Biol Interact; 2015 Jul; 237():25-30. PubMed ID: 25980584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line.
    Wang Z; Xia Q; Cui J; Diao Y; Li J
    Oncol Rep; 2014 Jun; 31(6):2720-6. PubMed ID: 24788927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells.
    Roncuzzi L; Pancotti F; Baldini N
    Oncol Rep; 2014 Jul; 32(1):389-94. PubMed ID: 24840054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of drug-regulated genes in osteosarcoma cells.
    Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
    Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
    Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
    Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ERK/eIF4F/Bcl-XL pathway mediates SGP-2 induced osteosarcoma cells apoptosis in vitro and in vivo.
    Zhang Z; Zheng Y; Zhu R; Zhu Y; Yao W; Liu W; Gao X
    Cancer Lett; 2014 Oct; 352(2):203-13. PubMed ID: 25025927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.
    Eliseev RA; Schwarz EM; Zuscik MJ; O'Keefe RJ; Drissi H; Rosier RN
    Exp Cell Res; 2006 Jan; 312(1):40-50. PubMed ID: 16259979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pien Tze Huang induces apoptosis in multidrug‑resistant U2OS/ADM cells via downregulation of Bcl‑2, survivin and P-gp and upregulation of Bax.
    Zhang Y; Wang Q; Niu S; Liu J; Zhang L
    Oncol Rep; 2014 Feb; 31(2):763-70. PubMed ID: 24337940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.